MINAPHARM Pharmaceuticals (EGX:MIPH)

Egypt · Delayed Price · Currency is EGP

669.42

+15.74 (2.41%)

At close: Jun 4, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Bio Production	2.85B	-	-	-	-
Drug Production	1.04B	-	-	-	-
Other Supplies	1.71B	-	-	-	-
Commercial Sales	65.12M	-	-	-	-
Total	5.66B	-	-	-	-

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Sales inside Arab Republic of Egypt	3.43B	2.52B	2.32B	2.11B	1.74B
Sales inside Arab Republic of Egypt Growth	35.75%	8.92%	9.89%	21.38%	-15.29%
Sales outside Arab Republic of Egypt	2.24B	1.37B	1.30B	14.22M	623.64M
Sales outside Arab Republic of Egypt Growth	63.62%	4.97%	9063.31%	-97.72%	-
Unallocated	-	-	-	882.24M	-
Total	5.66B	3.89B	3.62B	3.01B	2.36B
Total Growth	45.55%	7.50%	20.47%	27.29%	15.11%

Source: S&P Global Market Intelligence.